Diversified Healthcare Trust(DHC)
$7.40+0.08 (+5.41%)
DHC
Diversified Healthcare Trust financials statements
$7.40
At close:+0.08 (+5.41%)
Want to see DHC full AI Analyst Report?
Diversified Healthcare Trust (DHC) Ratios
626 Followers
Diversified Healthcare Trust Ratios
DHC's free cash flow for Q3 2026 was $521.00K. For the 2026 fiscal year, DHC's free cash flow was decreased by $-26.87M and operating cash flow was $27.39M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 100.72 | 11.29 | 8.77 | 0.95 | 36.83 |
| Quick Ratio | 100.72 | 11.29 | 8.77 | 0.95 | 36.83 |
| Cash Ratio | 65.27 | 3.79 | 8.21 | 0.90 | 21.27 |
| Solvency Ratio | -0.01 | -0.03 | -0.00 | 0.07 | 0.11 |
| Operating Cash Flow Ratio | -10.51 | 2.95 | 0.35 | -0.05 | -2.12 |
| Short-Term Operating Cash Flow Coverage | -10.51 | 0.00 | 0.00 | -0.06 | 0.00 |
| Net Current Asset Value | $ -2.51B | $ -2.75B | $ -2.85B | $ -2.67B | $ -2.86B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.55 | 0.57 | 0.52 | 0.51 | 0.56 |
| Debt-to-Equity Ratio | 1.45 | 1.49 | 1.21 | 1.17 | 1.38 |
| Debt-to-Capital Ratio | 0.59 | 0.60 | 0.55 | 0.54 | 0.58 |
| Long-Term Debt-to-Capital Ratio | 0.59 | 0.60 | 0.55 | 0.47 | 0.58 |
| Financial Leverage Ratio | 2.62 | 2.62 | 2.33 | 2.27 | 2.49 |
| Debt Service Coverage Ratio | 0.87 | 0.98 | 1.03 | 0.47 | 2.76 |
| Interest Coverage Ratio | -0.19 | 0.98 | 1.04 | -0.44 | -0.05 |
| Debt to Market Cap | 2.06 | 5.28 | 3.15 | 19.77 | 4.99 |
| Interest Debt Per Share | 10.91 | 13.13 | 12.60 | 13.79 | 16.54 |
| Net Debt to EBITDA | 12.60 | 12.03 | 12.92 | 5.66 | 4.30 |
| Profitability Margins | |||||
| Gross Profit Margin | -15.95% | 17.14% | 15.98% | 13.59% | 21.07% |
| EBIT Margin | -5.18% | -3.68% | -6.02% | 14.67% | 31.60% |
| EBITDA Margin | 11.85% | 15.38% | 14.11% | 33.33% | 51.20% |
| Operating Profit Margin | -2.55% | 15.37% | 14.12% | -7.11% | -1.00% |
| Pretax Profit Margin | -18.48% | -24.73% | -20.78% | -1.17% | 13.11% |
| Net Profit Margin | -18.59% | -24.76% | -20.82% | -1.23% | 12.62% |
| Continuous Operations Profit Margin | -18.59% | -24.76% | -20.82% | -1.23% | 13.01% |
| Net Income Per EBT | 100.61% | 100.13% | 100.15% | 104.71% | 96.23% |
| EBT Per EBIT | 723.60% | -160.88% | -147.17% | 16.51% | -1312.46% |
| Return on Assets (ROA) | -6.56% | -7.21% | -5.39% | -0.26% | 2.63% |
| Return on Equity (ROE) | -17.16% | -18.90% | -12.56% | -0.60% | 6.55% |
| Return on Capital Employed (ROCE) | -0.90% | 4.51% | 3.68% | -1.73% | -0.21% |
| Return on Invested Capital (ROIC) | -0.90% | 4.51% | 3.73% | -1.53% | -0.21% |
| Return on Tangible Assets | -6.59% | -7.24% | -5.42% | -0.26% | 2.65% |
| Earnings Yield | -24.53% | -67.21% | -32.87% | -10.23% | 23.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 23.25 | 368.60 | 231.92 | 147.27 | 16.84 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 92.99 | 0.00 | 60.36 | 0.00 | 0.27 |
| Asset Turnover | 0.35 | 0.29 | 0.26 | 0.21 | 0.21 |
| Working Capital Turnover Ratio | 5.32 | 4.79 | 14.44 | 2.49 | 2.63 |
| Cash Conversion Cycle | 15.70 | 0.99 | 1.57 | 2.48 | 21.67 |
| Days of Sales Outstanding | 15.70 | 0.99 | 1.57 | 2.48 | 21.67 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 15.70 | 0.99 | 1.57 | 2.48 | 21.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.08 | 0.47 | 0.04 | -0.17 | -0.27 |
| Free Cash Flow Per Share | -0.08 | 0.47 | 0.04 | -0.17 | -0.27 |
| Dividend Paid and CapEx Coverage Ratio | -2.03 | 11.66 | 1.09 | -4.22 | -6.64 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.01 | 0.04 | 0.00 | -0.01 | -0.02 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.08 | 0.01 | -0.03 | -0.05 |
| Free Cash Flow Yield | -1.68% | 20.37% | 1.17% | -26.18% | -8.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.08 | -1.49 | -3.04 | -9.77 | 4.21 |
| Price-to-Sales (P/S) Ratio | 0.76 | 0.37 | 0.63 | 0.12 | 0.53 |
| Price-to-Book (P/B) Ratio | 0.70 | 0.28 | 0.38 | 0.06 | 0.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -59.40 | 4.91 | 85.21 | -3.82 | -11.61 |
| Price-to-Operating Cash Flow Ratio | -59.40 | 4.91 | 85.21 | -3.82 | -11.61 |
| Price-to-Earnings Growth (PEG) Ratio | 0.18 | -0.06 | -0.00 | 0.09 | -0.02 |
| Enterprise Value Multiple | 18.99 | 14.43 | 17.41 | 6.02 | 5.34 |
| Enterprise Value | 3.46B | 3.32B | 3.46B | 2.57B | 3.78B |
| EV to EBITDA | 18.99 | 14.43 | 17.41 | 6.02 | 5.34 |
| EV to Sales | 2.25 | 2.22 | 2.46 | 2.01 | 2.73 |
| EV to Free Cash Flow | -176.45 | 29.56 | 330.45 | -63.79 | -59.72 |
| EV to Operating Cash Flow | -176.45 | 29.56 | 330.45 | -63.79 | -59.72 |
| Tangible Book Value Per Share | 6.85 | 8.07 | 9.64 | 11.07 | 10.98 |
| Shareholders’ Equity Per Share | 6.93 | 8.18 | 9.78 | 11.07 | 11.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.00 | -0.05 | 0.01 |
| Revenue Per Share | 6.40 | 6.24 | 5.90 | 5.39 | 5.81 |
| Net Income Per Share | -1.19 | -1.55 | -1.23 | -0.07 | 0.73 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.05 | 0.96 |
| Interest Burden | 3.57 | 6.71 | 3.45 | -0.08 | 0.41 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.07 | -0.30 | -0.04 | 2.56 | -0.35 |
Currency in USD
